why choose us

Clinical Trials Search

Showing 7,740 of 132,656 result(s)
Clinical Performance Evaluation of T-TAS®01 HD Chip

Status: Completed

Condition: Thrombocytopenia

Interventions: Disposable flow chamber microchip containing thrombogenic path to facilitate thrombus formation and occlusion

Date: 2023-10-11

A Multi-Center, Open Label Gene Therapy Study of RP-A501 in Male Patients With Danon Disease

Status: Completed

Condition: Danon Disease

Interventions: RP-A501 is a gene therapy product consisting of a rAAV9 capsid containing the human LAMP2B transgene which will be administered as a single IV infusio

Date: 2023-10-11

Non-invasive Brain Stimulation and Injury Risk Biomechanics

Status: Completed

Condition: Concussion, Mild

Interventions:

The repetitive transcranial magnetic stimulation device will generate successive magnetic pulses to the left dorsolateral prefrontal cortex (experi

Date: 2023-10-11

Maimonides Minocycline in Stroke Study

Status: Completed

Condition: Stroke, Acute

Interventions: Minocycline 200 mg every 24 hours for five days to be initiated within 24hr of stroke onset.

Date: 2023-10-11

Mirdametinib in Histiocytic Disorders

Status: Completed

Condition: Langerhans Cell Histiocytosis (LCH)

Interventions: Mirdametinib is administered at a dose of 2 mg;m2, twice a day (BID) with a maximum dose of 4 mg BID on a continuous daily schedule.
Consecu

Date: 2023-10-11

5-Day Preoperative Radiation for Soft Tissue Sarcoma

Status: Completed

Condition: Soft Tissue Sarcoma

Interventions: Radiation will be delivered by external beam techniques to the tumor and areas of possible microscopic disease at a dose of 30 Gy divided into 5 equal

Date: 2023-10-11

Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy

Status: COMPLETED

Condition: Cancer

Interventions: Clinical data for all enrolled patients will be abstracted from the electronic medical record.
This will include but will not be limited to patie

Date: 2023-10-11

A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Status: COMPLETED

Condition: Alzheimer's Disease (AD)

Interventions: Drug: SHR-1707 SHR-1707 will be administered through IV infusion.
Drug: Placebo Placebo will be administered through IV infusion

Date: 2023-10-11

Perineural Dexamethasone in Supraclavicular Brachial Plexus Block for Anesthesia After Pediatric Hand;Wrist Surgery

Status: COMPLETED

Condition: Wrist Disease

Interventions: administration of 0.5ml;kg of 0,2% ropivacaine + 0.01ml;kg 0.9% sodium chloride for the supraclavicular brachial plexus block

Date: 2023-10-11